References
1. E. Lanez, "Mediator : l'effarante boîte à mensonges" (Le Point.fr, 2011)
http://www.lepoint.fr, accessed Jan. 9, 2012.
2. B. Casassus, "With New Law, France Revamps Drug Approval" (Science, 2011). http://news.sciencemag.org/, accessed Jan. 9, 2012.
3. Servier, "Research is as vital as being an industry " (Servier website, 2011).
http://www.servier.com/, accessed 9 Jan., 2012.
4. J. Upton, "Servier: patience and passion," Pharmaceutical Executive Europe (November 2008).
5. Focus Reports, "Interview—Jacques Servier" (2011).
http://www.pharma.focusreports.net/, accessed 9 Jan., 2012.
6. K. Grogan, "Servier signs cancer deal with Sweden's BioInvent" (Pharma Times, 2012).
http://www.pharmatimes.com/, accessed Jan. 9, 2012.
7. European Biotechnology Science & Industry News "Galapagos gets €4 million in alliance with Servier" (2011).
http://www.eurobiotechnews.eu, accessed 9 Jan., 2012.
8. N. Jessop, Pharm. Technol. Eur.
23 (3), 14–18 (2011).
9. Le Point.fr, "Mediator, un jugement pour 2012?" (2011).
http://www.lepoint.fr, accessed Jan. 9, 2012.
10. S. Sayare, "Scandal Over Mediator, a French Weight-Loss Drug, Prompts Calls for Wide Changes" (New York Times, 2011).
http://www.nytimes.com/, accessed Jan. 9, 2012
11. Assemblée Nationale (2011).
http://www.assemblee-nationale.fr/13/rap-info/i3552.asp, accessed Jan. 11, 2012
12. InPharm, "2011 Year In Review" (2012).
http://www.inpharm.com/, accessed Jan. 9, 2012.
13. Le Nouvel Observateur, "Mediator: la cour rejette le regroupement des procédures" (2011). http://tempsreel.nouvelobs.com/, accessed Jan. 11, 2012.
|
